# 62332-601-25 · Ketorolac Tromethamine Injection · Alembic Pharmaceuticals — FDA drug shortage duration tracker

For 62332-601-25 · Ketorolac Tromethamine Injection · Alembic Pharmaceuticals, package ndc is 62332-601-25; generic name is Ketorolac Tromethamine Injection; manufacturer is Alembic Pharmaceuticals; status is Current; availability now is Available, recorded from its source on 2026-09-01.

- **Package NDC:** 62332-601-25 _(verified: appears in the quote below)_
- **Generic name:** Ketorolac Tromethamine Injection _(verified: appears in the quote below)_
- **Manufacturer:** Alembic Pharmaceuticals _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **Initial posting date:** 03/23/2018 _(verified: appears in the quote below)_
- **Last update date:** 05/15/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 3084 _(our reading, not quoted from the source)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Analgesia/Addiction _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "03/23/2018", "package_ndc": "62332-601-25", "generic_name": "Ketorolac Tromethamine Injection", "contact_info": "908-393-9604", "availability": "Available"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "05/15/2026", "therapeutic_category": [ "Analgesia/Addiction" ], "dosage_form": "Injection", "presentation": "Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25)", "company_name": "Alembic Pharmaceuticals", "status": "Current"

### Status

> "update_date": "05/15/2026", "therapeutic_category": [ "Analgesia/Addiction" ], "dosage_form": "Injection", "presentation": "Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25)", "company_name": "Alembic Pharmaceuticals", "status": "Current"

### Last update date

> "update_date": "05/15/2026", "therapeutic_category": [ "Analgesia/Addiction" ], "dosage_form": "Injection", "presentation": "Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25)", "company_name": "Alembic Pharmaceuticals", "status": "Current"

### Dosage form

> "update_date": "05/15/2026", "therapeutic_category": [ "Analgesia/Addiction" ], "dosage_form": "Injection", "presentation": "Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25)", "company_name": "Alembic Pharmaceuticals", "status": "Current"

### Therapeutic category

> "update_date": "05/15/2026", "therapeutic_category": [ "Analgesia/Addiction" ], "dosage_form": "Injection", "presentation": "Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25)", "company_name": "Alembic Pharmaceuticals", "status": "Current"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alembic%20Pharmaceuticals%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-01. Review by: 2026-09-04.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).